<DOC>
	<DOCNO>NCT02711865</DOCNO>
	<brief_summary>The main goal study employ novel proteomic approach identify predictive tumor biomarkers increase efficacy insulin-like growth factor ( IGF1R ) target therapy epithelial ovarian cancer . It expect predictive biomarkers apply increase response rate select group patient .</brief_summary>
	<brief_title>Predictive Biomarkers IGF1R Targeted Therapy Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Patients ovarian cancer All others</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>